Biostar Pharmaceuticals (BSPM) Earning Somewhat Favorable Media Coverage, Study Shows

Media stories about Biostar Pharmaceuticals (NASDAQ:BSPM) have been trending somewhat positive recently, according to Accern. The research firm identifies negative and positive media coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Biostar Pharmaceuticals earned a news impact score of 0.17 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 46.0869025241411 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

Biostar Pharmaceuticals (NASDAQ:BSPM) traded up $0.07 during midday trading on Thursday, hitting $1.91. 40,100 shares of the stock were exchanged, compared to its average volume of 76,774. Biostar Pharmaceuticals has a 12 month low of $1.18 and a 12 month high of $4.30. The firm has a market capitalization of $4.85, a P/E ratio of 2.63 and a beta of 1.87.

Biostar Pharmaceuticals (NASDAQ:BSPM) last posted its quarterly earnings data on Wednesday, November 15th. The company reported ($0.50) earnings per share (EPS) for the quarter. During the same quarter in the prior year, the business posted ($3.12) EPS.

COPYRIGHT VIOLATION NOTICE: This piece of content was originally reported by Community Financial News and is the sole property of of Community Financial News. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of United States & international copyright legislation. The legal version of this piece of content can be read at

Biostar Pharmaceuticals Company Profile

Biostar Pharmaceuticals, Inc (Biostar) is a holding company. The Company, through its subsidiary, Shaanxi Biostar Biotech, Ltd. (Shaanxi Biostar), and its variable interest entities (VIEs), Shaanxi Aoxing Pharmaceutical Co, Ltd. (Aoxing Pharmaceutical) and Shaanxi Weinan Huaren Pharmaceuticals Ltd. (Shaanxi Weinan), develops, manufactures and markets pharmaceutical products for various diseases and conditions in the People’s Republic of China (PRC or China).

Insider Buying and Selling by Quarter for Biostar Pharmaceuticals (NASDAQ:BSPM)

Receive News & Ratings for Biostar Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biostar Pharmaceuticals and related companies with's FREE daily email newsletter.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit